COVID-19 NOTIFICATION: To protect your safety in response to the threat of COVID-19, our staff is still available to serve you during our normal office hours. We are offering our clients and potential clients the option to connect with us via telephone, email and video-conferencing. Please call or email us to discuss your options.

New Study Shows Invokana Increases the Risk of Amputations

| Feb 19, 2018 | Dangerous Or Defective Products, Defective Drugs

Warner Law Offices has recently become aware that the Type 2 diabetes drug, Invokana, puts users at an increased risk for leg, foot and toe amputations. The FDA issued the first safety warning regarding Invokana and amputation based on interim analysis of two clinical trials. Both studies have now been concluded and final results confirm that Invokana may double the amputation risk. Based on these final results, the FDA has issued a more severe, “black box warning” for Invokana.


Johnson & Johnson, the manufacturer of Invokana, has suffered one issue after another over the past few years, including those associated with transvaginal mesh, metal hip implants, talcum powder ovarian cancer claims, and now more issues with Invokana. Warner Law Offices is taking on all of these cases in an effort hold this corporation accountable for its failure to provide safe medical products.

Our attorneys know that only by banding together and sharing information can we effectively fight the propensity of big manufacturing companies to rush untested and dangerous products to the marketplace.

If you or a loved one have had a leg, foot or toe amputation while taking Invokana, please call me today. It is important that all those who have been injured join the fight against defective products while also getting the compensation they deserve.